UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor

Journal of clinical oncology, 2000-04, Vol.18 (8), p.1614-1621

2000

Volltextzugriff (PDF)

Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer

The Prostate, 2000-05, Vol.43 (2), p.88-100

2000

Volltextzugriff (PDF)

Immunologic approaches to the treatment of prostate cancer

Seminars in oncology, 1999-08, Vol.26 (4), p.439-447

1999

Volltextzugriff (PDF)

A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma

Journal of clinical oncology, 1991-05, Vol.9 (5), p.736-740

SPITLER, L. E

1991

Volltextzugriff (PDF)

Oil-in-water liposomal emulsions: Characterization and potential use in vaccine delivery

Journal of pharmaceutical sciences, 1999-12, Vol.88 (12), p.1332-1339

1999

Volltextzugriff (PDF)

Adjuvant therapy of melanoma: at what cost?

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1226-1228

Spitler, L E

2001

Volltextzugriff (PDF)

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin

Cancer research (Chicago, Ill.), 1987-03, Vol.47 (6), p.1717-1723

1987

Volltextzugriff (PDF)

Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients

Antimicrobial Agents and Chemotherapy, 1988-05, Vol.32 (5), p.710-716

1988

Volltextzugriff (PDF)

Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma

Critical reviews in oncology/hematology, 2001-07, Vol.39 (1), p.115-123

2001

Volltextzugriff (PDF)

Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody

Radiology, 1986-11, Vol.161 (2), p.419-422

1986

Volltextzugriff (PDF)

Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats

Cancer research (Chicago, Ill.), 1987-03, Vol.47 (5), p.1377-1382

1987

Volltextzugriff (PDF)

Phase II trial of nab-paclitaxel and bevacizumab as first-line therapy in patients with unresectable melanoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8543-8543

2011

Volltextzugriff (PDF)

Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma

Journal of immunotherapy, 2009-07, Vol.32 (6), p.632-637

2009

Volltextzugriff (PDF)

Immunological effects and clinical outcomes in patients with high-risk melanoma given adjuvant therapy with granulocyte-macrophage colony stimulating factor (GM-CSF, sargramostim)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20004-e20004

2009

Volltextzugriff (PDF)

A randomized, double‐blind, placebo‐controlled trial of transfer factor as adjuvant therapy for malignant melanoma

Cancer, 1988-04, Vol.61 (8), p.1543-1549

1988

Volltextzugriff (PDF)

Wiskott-Aldrich Syndrome, A Genetically Determined Cellular Immunologic Deficiency: Clinical and Laboratory Responses to Therapy with Transfer Factor

Proceedings of the National Academy of Sciences - PNAS, 1970-10, Vol.67 (2), p.821-828

1970

Volltextzugriff (PDF)

Transfer factor: failure to transfer reactivity in normal human subjects

Clinical and experimental immunology, 1980-03, Vol.39 (3), p.708-716

Spitler, L E

1980

Volltextzugriff (PDF)

Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity

Clinical and experimental immunology, 1983-07, Vol.53 (1), p.133-139

1983

Volltextzugriff (PDF)

Purification of monoclonal antibodies from mouse ascites eliminates contaminating infectious mouse type C viruses and nucleic acids

Clinical and experimental immunology, 1984-04, Vol.56 (1), p.114-120

1984

Volltextzugriff (PDF)

Serum copper and zinc levels in melanoma patients

Cancer, 1981-04, Vol.47 (7), p.1838-1844

1981

Volltextzugriff (PDF)

Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma

Cancer biotherapy & radiopharmaceuticals, 1998-06, Vol.13 (3), p.165-176

1998

Volltextzugriff (PDF)

Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis

Clinical and experimental immunology, 1979-04, Vol.36 (1), p.78-84

1979

Volltextzugriff (PDF)

Humoral immune response to a ricin A chain immunotoxin in patients with metastatic melanoma

Cancer drug delivery, 1987, Vol.4 (4), p.245-253

1987

Volltextzugriff (PDF)

Granulocyte-macrophage colony stimulating factor (GM-CSF, sargramostim) as adjuvant therapy of melanoma

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.20006-20006

2008

Volltextzugriff (PDF)

Malignant Melanoma

Journal of investigative dermatology, 1976-09, Vol.67 (3), p.435-441

Spitler, Lynn E

1976

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(138)

Publikationsform

Sprache

Englisch
(208)
Deutsch
(2)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant Therapy of Stage III and IV Malignant Melanoma Using Granulocyte-Macrophage Colony-Stimulating Factor

Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer

Immunologic approaches to the treatment of prostate cancer

A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma

Oil-in-water liposomal emulsions: Characterization and potential use in vaccine delivery

Adjuvant therapy of melanoma: at what cost?

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin

Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients

Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma

Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody

Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats

Phase II trial of nab-paclitaxel and bevacizumab as first-line therapy in patients with unresectable melanoma

Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV melanoma

Immunological effects and clinical outcomes in patients with high-risk melanoma given adjuvant therapy with granulocyte-macrophage colony stimulating factor (GM-CSF, sargramostim)

A randomized, double‐blind, placebo‐controlled trial of transfer factor as adjuvant therapy for malignant melanoma

Wiskott-Aldrich Syndrome, A Genetically Determined Cellular Immunologic Deficiency: Clinical and Laboratory Responses to Therapy with Transfer Factor

Transfer factor: failure to transfer reactivity in normal human subjects

Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity

Purification of monoclonal antibodies from mouse ascites eliminates contaminating infectious mouse type C viruses and nucleic acids

Serum copper and zinc levels in melanoma patients

Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma

Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis

Humoral immune response to a ricin A chain immunotoxin in patients with metastatic melanoma

Granulocyte-macrophage colony stimulating factor (GM-CSF, sargramostim) as adjuvant therapy of melanoma

Malignant Melanoma

Suchergebnisse filtern